Skip to main content

Table 3 Independent predictors of all-cause mortality at 20 years in the sub group with baseline TG ≥200 mg/dL

From: Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial

 

HR

95 % CI

P value

Lower

Upper

Fibrate treatment

0.75

0.60

0.94

0.012

Past MI

1.53

1.15

2.00

0.004

Glucose

1.00

0.99

1.01

0.12

Age (per year increment)

1.08

1.07

1.11

<0.001

BMI (per unit)

1.01

0.98

1.05

0.39

NYHA functional class ≥ II

1.09

0.89

1.33

0.41

HDL-C (per 1 mg/dl)

1.00

0.97

1.02

0.76

Diabetes mellitus

1.88

1.36

2.61

<0.001

  1. Model further adjusted for hypertension, gender and non-study lipid lowering medication as a time dependent covariate (all p > 0.05)
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840